Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contribution of High Throughput RNA Sequencing Combined With Sequencing of Whole Genomes in the Diagnosis of Intellectual Disability.

NCT03857997 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Dijon as lead sponsor.

NCT NCT03857997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03857997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contribution of High Throughput RNA Sequencing Combined With Sequencing of Whole Genomes in the Diagnosis of Intellectual Disability.
Lead sponsor
Centre Hospitalier Universitaire Dijon
Phase
Observational
Overall status
Completed
Start date
February 4, 2019
Completion date
February 2, 2021
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients with intellectual disabilities without an obvious clinical diagnosis, patients with normal array cgh and previous negative genetic investigations (wes-solo or wes-trio)